Effectiveness of the National Diabetes Prevention Program After Gestational Diabetes.

Abstract

INTRODUCTION:

Women with previous gestational diabetes are at high risk of developing Type 2 diabetes. The National Diabetes Prevention Program (NDPP) is a widely disseminated lifestyle intervention to prevent Type 2 diabetes. Although NDPP programs are open to adults of any age, participants are usually older adults. Effectiveness among younger women with previous gestational diabetes is largely unknown.

METHODS:

The NDPP was delivered by lifestyle coaches in a large network of Federally Qualified Health Centers. Reach, retention, physical activity, and weight loss outcomes were compared between women aged <40 years with previous gestational diabetes and all other participants. Data were collected from 2013 to 2019 and analyzed in 2022.

RESULTS:

Among 2,865 enrollees who agreed to start the yearlong NDPP, 63.3% were Latinx, 18.8% were non-Latinx Black, and 16.4% were non-Latinx White. Younger women with previous gestational diabetes represented <4% (n=107) of participants. There was no significant difference in the frequency of attending ≥1 NDPP session between these women and all other participants (37.4% vs 44.6%; p=0.146). However, among those attending ≥1 session (n=1,265), younger women with previous gestational diabetes attended more (11.27 ± 1.27 vs 8.50 ± 0.22 sessions, p=0.021) and had greater weight loss (3.04% ± 0.59 vs. 1.49% ± 0.11, p=0.010) in covariate-adjusted models than other participants.

CONCLUSIONS:

Diverse younger women with previous gestational diabetes attending the NDPP had one third greater attendance and twice as much weight loss as other NDPP participants but represented a much smaller proportion of enrollees. Thus, the NDPP appears to be a beneficial but underutilized resource for this high-risk population.

• Authors: Natalie D Ritchie, Ellen W Seely, Jacinda M Nicklas, Sue E Levkoff
• Journal: American journal of preventive medicine (Am J Prev Med) Vol. 65 Issue 2 Pg. 317-321 (08 2023) ISSN: 1873-2607 [Electronic] Netherlands
• PMID: 36918133 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
• Copyright: Copyright © 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Chemical References

• 4-nitro-3-dimethylaminopropiophenone

Topics

• Pregnancy
• Female
• Humans
• Aged
• Diabetes, Gestational (prevention & control)
• Diabetes Mellitus, Type 2 (prevention & control)
• Life Style
• Weight Loss